CLDX vs IMDX
Celldex Therapeutics, Inc. - Common Stock · Insight Molecular Diagnostics Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | CLDX | IMDX |
|---|---|---|
| Price | $30.15 | $2.39 |
| Market Cap | $2.37B | $78.21M |
| P/E | — | — |
| P/B | 3.65 | — |
| P/S | 1532.77 | 19.29 |
| ROE | -39.8% | — |
| Net Margin | -16748.0% | -1238.5% |
| Gross Margin | — | 56.7% |
| Revenue Growth | -78.0% | 115.6% |
| Dividend Yield | — | — |
| EPS | -$3.29 | -$1.53 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.